{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:40:23Z","timestamp":1793400023623,"version":"4.5.0"},"reference-count":147,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFA1802100"],"award-info":[{"award-number":["2024YFA1802100"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFA0806400"],"award-info":[{"award-number":["2022YFA0806400"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["92357305"],"award-info":[{"award-number":["92357305"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82422017"],"award-info":[{"award-number":["82422017"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82341226"],"award-info":[{"award-number":["82341226"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370812"],"award-info":[{"award-number":["82370812"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82288102"],"award-info":[{"award-number":["82288102"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82130022"],"award-info":[{"award-number":["82130022"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012492","name":"Beijing Municipal Outstanding Young Talents","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Host & Microbe"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.chom.2025.04.020","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T11:41:05Z","timestamp":1748259665000},"page":"836-853","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Gut microbial enzymes and metabolic dysfunction-associated steatohepatitis: Function, mechanism, and therapeutic prospects"],"prefix":"10.1016","volume":"33","author":[{"given":"Xi","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5206-2372","authenticated-orcid":false,"given":"Changtao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chom.2025.04.020_bib1","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.chom.2025.04.020_bib2","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.chom.2025.04.020_bib3","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S2468-1253(21)00020-0","article-title":"Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach","volume":"6","author":"Targher","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.chom.2025.04.020_bib4","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/s11427-024-2551-3","article-title":"Gut microbial-host-isozymes are new targets for diseases","volume":"67","author":"Zhang","year":"2024","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.chom.2025.04.020_bib5","doi-asserted-by":"crossref","first-page":"8161","DOI":"10.3390\/ijms22158161","article-title":"The Role of Leaky Gut in Nonalcoholic Fatty Liver Disease: A Novel Therapeutic Target","volume":"22","author":"Kessoku","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.chom.2025.04.020_bib6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrgastro.2015.15","article-title":"NAFLD. Leaky guts: intestinal permeability and NASH","volume":"12","author":"Ray","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.chom.2025.04.020_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.770986","article-title":"Endotoxins and Non-Alcoholic Fatty Liver Disease","volume":"12","author":"Kessoku","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.chom.2025.04.020_bib8","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/hep.22848","article-title":"Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease","volume":"49","author":"Miele","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.chom.2025.04.020_bib9","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jcmgh.2015.01.001","article-title":"Hepatic Injury in Nonalcoholic Steatohepatitis Contributes to Altered Intestinal Permeability","volume":"1","author":"Luther","year":"2015","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.chom.2025.04.020_bib10","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1136\/gutjnl-2019-318811","article-title":"Intrahepatic bacterial metataxonomic signature in non-alcoholic fatty liver disease","volume":"69","author":"Sookoian","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.chom.2025.04.020_bib11","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/hep.31056","article-title":"Increased Liver Localization of Lipopolysaccharides in Human and Experimental NAFLD","volume":"72","author":"Carpino","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.chom.2025.04.020_bib12","article-title":"Inhibition of microbial deconjugation of micellar bile acids protects against intestinal permeability and liver injury","volume":"8","author":"Li","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.chom.2025.04.020_bib13","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1016\/j.cell.2024.03.034","article-title":"Gut symbionts alleviate MASH through a secondary bile acid biosynthetic pathway","volume":"187","author":"Nie","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.chom.2025.04.020_bib14","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.cmet.2024.07.004","article-title":"A microbial metabolite inhibits the HIF-2\u03b1-ceramide pathway to mediate the beneficial effects of time-restricted feeding on MASH","volume":"36","author":"Zhang","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.chom.2025.04.020_bib15","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/s42255-024-01043-6","article-title":"An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"6","author":"Vacca","year":"2024","journal-title":"Nat. Metab."},{"key":"10.1016\/j.chom.2025.04.020_bib16","article-title":"Western diet contributes to the pathogenesis of non-alcoholic steatohepatitis in male mice via remodeling gut microbiota and increasing production of 2-oleoylglycerol","volume":"14","author":"Yang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chom.2025.04.020_bib17","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s10620-016-4393-x","article-title":"Altered Gut Microbiota Composition and Immune Response in Experimental Steatohepatitis Mouse Models","volume":"62","author":"Ishioka","year":"2017","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.chom.2025.04.020_bib18","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1136\/gut.48.2.206","article-title":"The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis","volume":"48","author":"Wigg","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.chom.2025.04.020_bib19","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41575-020-0269-9","article-title":"Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders","volume":"17","author":"Aron-Wisnewsky","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.chom.2025.04.020_bib20","doi-asserted-by":"crossref","first-page":"6550","DOI":"10.1016\/j.cell.2024.09.019","article-title":"A core microbiome signature as an indicator of health","volume":"187","author":"Wu","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.chom.2025.04.020_bib21","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nrmicro2974","article-title":"The gut microbiota--masters of host development and physiology","volume":"11","author":"Sommer","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.chom.2025.04.020_bib22","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nature11234","article-title":"Structure, function and diversity of the healthy human microbiome","volume":"486","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.chom.2025.04.020_bib23","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature08821","article-title":"A human gut microbial gene catalogue established by metagenomic sequencing","volume":"464","author":"Qin","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.chom.2025.04.020_bib24","doi-asserted-by":"crossref","first-page":"357ra122","DOI":"10.1126\/scitranslmed.aaf4823","article-title":"Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet-fed mice","volume":"8","author":"Rao","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.chom.2025.04.020_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110835","article-title":"ASBT(SLC10A2): A promising target for treatment of diseases and drug discovery","volume":"132","author":"Yang","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.chom.2025.04.020_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0218459","article-title":"Apical sodium-dependent bile acid transporter inhibition with volixibat improves metabolic aspects and components of non-alcoholic steatohepatitis in Ldlr-\/-.Leiden mice","volume":"14","author":"Salic","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.chom.2025.04.020_bib27","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s40168-021-01101-1","article-title":"Review: microbial transformations of human bile acids","volume":"9","author":"Guzior","year":"2021","journal-title":"Microbiome"},{"key":"10.1016\/j.chom.2025.04.020_bib28","doi-asserted-by":"crossref","first-page":"7164","DOI":"10.1016\/j.cell.2024.10.001","article-title":"Structure-guided discovery of bile acid derivatives for treating liver diseases without causing itch","volume":"187","author":"Yang","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.chom.2025.04.020_bib29","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1038\/s41564-022-01176-y","article-title":"A biosynthetic pathway for the selective sulfonation of steroidal metabolites by human gut bacteria","volume":"7","author":"Yao","year":"2022","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.chom.2025.04.020_bib30","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrgastro.2017.119","article-title":"Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis","volume":"15","author":"Jia","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.chom.2025.04.020_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007581","article-title":"Bile salt hydrolases: Gatekeepers of bile acid metabolism and host-microbiome crosstalk in the gastrointestinal tract","volume":"15","author":"Foley","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.chom.2025.04.020_bib32","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1080\/19490976.2020.1748261","article-title":"Metagenomic analysis of the human microbiome reveals the association between the abundance of gut bile salt hydrolases and host health","volume":"11","author":"Jia","year":"2020","journal-title":"Gut Microbes"},{"key":"10.1016\/j.chom.2025.04.020_bib33","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1053\/j.gastro.2017.01.055","article-title":"Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease","volume":"152","author":"Ch\u00e1vez-Talavera","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.chom.2025.04.020_bib34","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41575-021-00566-7","article-title":"Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology","volume":"19","author":"Fuchs","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.chom.2025.04.020_bib35","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1172\/JCI76738","article-title":"Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease","volume":"125","author":"Jiang","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.chom.2025.04.020_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10166","article-title":"Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction","volume":"6","author":"Jiang","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chom.2025.04.020_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms8629","article-title":"Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells","volume":"6","author":"Trabelsi","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chom.2025.04.020_bib38","doi-asserted-by":"crossref","DOI":"10.1172\/JCI142865","article-title":"Suppressing the intestinal farnesoid X receptor\/sphingomyelin phosphodiesterase 3 axis decreases atherosclerosis","volume":"131","author":"Wu","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.chom.2025.04.020_bib39","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nm.3760","article-title":"Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance","volume":"21","author":"Fang","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.chom.2025.04.020_bib40","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1002\/hep.29857","article-title":"Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism","volume":"68","author":"Pathak","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.chom.2025.04.020_bib41","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41586-020-2396-4","article-title":"A metabolic pathway for bile acid dehydroxylation by the gut microbiome","volume":"582","author":"Funabashi","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.chom.2025.04.020_bib42","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1136\/gutjnl-2017-314307","article-title":"Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD","volume":"67","author":"Jiao","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.chom.2025.04.020_bib43","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/MOL.0000000000000597","article-title":"Bile acid alterations in nonalcoholic fatty liver disease, obesity, insulin resistance and type 2 diabetes: what do the human studies tell?","volume":"30","author":"Ch\u00e1vez-Talavera","year":"2019","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.chom.2025.04.020_bib44","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nature12347","article-title":"Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome","volume":"499","author":"Yoshimoto","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.chom.2025.04.020_bib45","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1002\/hep.32568","article-title":"Metabolic reprogramming of the intestinal microbiome with functional bile acid changes underlie the development of NAFLD","volume":"76","author":"Smirnova","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.chom.2025.04.020_bib46","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/S0022-2275(20)40663-7","article-title":"Epimerization of the 7-hydroxy group of bile acids by the combination of two kinds of microorganisms with 7 alpha- and 7 beta-hydroxysteroid dehydrogenase activity, respectively","volume":"22","author":"Hirano","year":"1981","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.chom.2025.04.020_bib47","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.jhep.2010.10.009","article-title":"UDCA for NASH: end of the story?","volume":"54","author":"Haedrich","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.chom.2025.04.020_bib48","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.jhep.2010.08.030","article-title":"A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis","volume":"54","author":"Ratziu","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.chom.2025.04.020_bib49","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/s41586-023-06906-8","article-title":"Reverse metabolomics for the discovery of chemical structures from humans","volume":"626","author":"Gentry","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.chom.2025.04.020_bib50","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/s41586-024-07017-8","article-title":"Bile salt hydrolase acyltransferase activity expands bile acid diversity","volume":"626","author":"Guzior","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.chom.2025.04.020_bib51","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/s41586-023-06990-w","article-title":"Bile salt hydrolase catalyses formation of amine-conjugated bile acids","volume":"626","author":"Rimal","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.chom.2025.04.020_bib52","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41586-020-2047-9","article-title":"Global chemical effects of the microbiome include new bile-acid conjugations","volume":"579","author":"Quinn","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.chom.2025.04.020_bib53","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.tem.2015.11.008","article-title":"The Role of Cholesterol in the Pathogenesis of NASH","volume":"27","author":"Ioannou","year":"2016","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.chom.2025.04.020_bib54","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.chom.2020.05.013","article-title":"Cholesterol Metabolism by Uncultured Human Gut Bacteria Influences Host Cholesterol Level","volume":"28","author":"Kenny","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.chom.2025.04.020_bib55","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.cell.2024.03.014","article-title":"Gut microbiome and metabolome profiling in Framingham heart study reveals cholesterol-metabolizing bacteria","volume":"187","author":"Li","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.chom.2025.04.020_bib56","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/nm1480","article-title":"Cholesterol glucosylation promotes immune evasion by Helicobacter pylori","volume":"12","author":"Wunder","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.chom.2025.04.020_bib57","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/s41564-022-01195-9","article-title":"Characterization of interactions of dietary cholesterol with the murine and human gut microbiome","volume":"7","author":"Le","year":"2022","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.chom.2025.04.020_bib58","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1210\/clinem\/dgad766","article-title":"Cushing Syndrome Is Associated With Gut Microbial Dysbiosis and Cortisol-Degrading Bacteria","volume":"109","author":"Zhang","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.chom.2025.04.020_bib59","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1016\/j.cell.2024.05.005","article-title":"Gut bacteria convert glucocorticoids into progestins in the presence of hydrogen gas","volume":"187","author":"McCurry","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.chom.2025.04.020_bib60","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.chom.2022.01.001","article-title":"3\u03b2-Hydroxysteroid dehydrogenase expressed by gut microbes degrades testosterone and is linked to depression in males","volume":"30","author":"Li","year":"2022","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.chom.2025.04.020_bib61","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.cmet.2023.02.017","article-title":"Gut-microbiome-expressed 3\u03b2-hydroxysteroid dehydrogenase degrades estradiol and is linked to depression in premenopausal females","volume":"35","author":"Li","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.chom.2025.04.020_bib62","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1126\/science.abf8403","article-title":"Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis","volume":"374","author":"Pernigoni","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.chom.2025.04.020_bib63","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s13679-024-00556-1","article-title":"Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease","volume":"13","author":"Polyzos","year":"2024","journal-title":"Curr. Obes. Rep."},{"key":"10.1016\/j.chom.2025.04.020_bib64","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1210\/er.2018-00158","article-title":"Reproductive Endocrinology of Nonalcoholic Fatty Liver Disease","volume":"40","author":"Grossmann","year":"2019","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.chom.2025.04.020_bib65","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/hep.30626","article-title":"Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps","volume":"70","author":"Lonardo","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.chom.2025.04.020_bib66","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/hep.26093","article-title":"Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH","volume":"57","author":"Zhu","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.chom.2025.04.020_bib67","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1007\/s10620-012-2112-9","article-title":"Nutrition, intestinal permeability, and blood ethanol levels are altered in patients with nonalcoholic fatty liver disease (NAFLD)","volume":"57","author":"Volynets","year":"2012","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.chom.2025.04.020_bib68","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1053\/gast.2000.19267","article-title":"Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis","volume":"119","author":"Cope","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.chom.2025.04.020_bib69","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/s41591-022-02016-6","article-title":"Microbiome-derived ethanol in nonalcoholic fatty liver disease","volume":"28","author":"Meijnikman","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.chom.2025.04.020_bib70","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jnutbio.2015.08.012","article-title":"Glutamine supplementation attenuates ethanol-induced disruption of apical junctional complexes in colonic epithelium and ameliorates gut barrier dysfunction and fatty liver in mice","volume":"27","author":"Chaudhry","year":"2016","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.chom.2025.04.020_bib71","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.jhep.2010.12.034","article-title":"Synergistic steatohepatitis by moderate obesity and alcohol in mice despite increased adiponectin and p-AMPK","volume":"55","author":"Xu","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.chom.2025.04.020_bib72","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.cmet.2019.08.018","article-title":"Fatty Liver Disease Caused by High-Alcohol-Producing Klebsiella pneumoniae","volume":"30","author":"Yuan","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.chom.2025.04.020_bib73","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3390\/nu10040440","article-title":"Folate and B12 Levels Correlate with Histological Severity in NASH Patients","volume":"10","author":"Mahamid","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.chom.2025.04.020_bib74","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.yclnex.2019.11.004","article-title":"Association between serum folate levels and fatty liver disease","volume":"29","author":"Vahedi","year":"2020","journal-title":"Clin. Nutr. Exp."},{"key":"10.1016\/j.chom.2025.04.020_bib75","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.jhep.2022.06.033","article-title":"Vitamin B12 and folate decrease inflammation and fibrosis in NASH by preventing syntaxin 17 homocysteinylation","volume":"77","author":"Tripathi","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.chom.2025.04.020_bib76","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.2310\/JIM.0b013e31822a29f5","article-title":"Association between serum vitamin B12 levels and the degree of steatosis in patients with nonalcoholic fatty liver disease","volume":"59","author":"Koplay","year":"2011","journal-title":"J. Investig. Med."},{"key":"10.1016\/j.chom.2025.04.020_bib77","article-title":"Vitamin C and vitamin D3 alleviate metabolic-associated fatty liver disease by regulating the gut microbiota and bile acid metabolism via the gut-liver axis","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.chom.2025.04.020_bib78","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.livres.2021.03.004","article-title":"Vitamins and non-alcoholic fatty liver disease: A Molecular Insight\u22c6","volume":"5","author":"Raza","year":"2021","journal-title":"Liver Res."},{"key":"10.1016\/j.chom.2025.04.020_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108005","article-title":"Activation of a Specific Gut Bacteroides-Folate-Liver Axis Benefits for the Alleviation of Nonalcoholic Hepatic Steatosis","volume":"32","author":"Qiao","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.chom.2025.04.020_bib80","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-18195-8","article-title":"The effects of vitamin B12 supplementation on metabolic profile of patients with non-alcoholic fatty liver disease: a randomized controlled trial","volume":"12","author":"Talari","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.chom.2025.04.020_bib81","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/ijo.2016.23","article-title":"Reprogramming of hepatic fat accumulation and \u2018browning\u2019 of adipose tissue by the short-chain fatty acid acetate","volume":"40","author":"Sahuri-Arisoylu","year":"2016","journal-title":"Int. J. Obes. (Lond.)"},{"key":"10.1016\/j.chom.2025.04.020_bib82","doi-asserted-by":"crossref","first-page":"5982","DOI":"10.1021\/jf900470c","article-title":"Acetic acid upregulates the expression of genes for fatty acid oxidation enzymes in liver to suppress body fat accumulation","volume":"57","author":"Kondo","year":"2009","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.chom.2025.04.020_bib83","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1530\/JOE-20-0018","article-title":"SCFAs alleviated steatosis and inflammation in mice with NASH induced by MCD","volume":"245","author":"Deng","year":"2020","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.chom.2025.04.020_bib84","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.3390\/nu16152454","article-title":"Effect of Supplementation of a Butyrate-Based Formula in Individuals with Liver Steatosis and Metabolic Syndrome: A Randomized Double-Blind Placebo-Controlled Clinical Trial","volume":"16","author":"Fogacci","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.chom.2025.04.020_bib85","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/dom.13500","article-title":"The effects of dietary supplementation with inulin and inulin-propionate ester on hepatic steatosis in adults with non-alcoholic fatty liver disease","volume":"21","author":"Chambers","year":"2019","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.chom.2025.04.020_bib86","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1136\/gutjnl-2014-307913","article-title":"Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults","volume":"64","author":"Chambers","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.chom.2025.04.020_bib87","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2420765","article-title":"How important are fatty acids in human health and can they be used in treating diseases?","volume":"16","author":"Dicks","year":"2024","journal-title":"Gut Microbes"},{"key":"10.1016\/j.chom.2025.04.020_bib88","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.chom.2023.11.005","article-title":"Bacteroides methylmalonyl-CoA mutase produces propionate that promotes intestinal goblet cell differentiation and homeostasis","volume":"32","author":"Wang","year":"2024","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.chom.2025.04.020_bib89","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","article-title":"From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites","volume":"165","author":"Koh","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.chom.2025.04.020_bib90","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1021\/pr501121c","article-title":"Hepatic and fecal metabolomic analysis of the effects of Lactobacillus rhamnosus GG on alcoholic fatty liver disease in mice","volume":"14","author":"Shi","year":"2015","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.chom.2025.04.020_bib91","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.3390\/molecules20022425","article-title":"A review of odd-chain fatty acid metabolism and the role of pentadecanoic Acid (c15:0) and heptadecanoic Acid (c17:0) in health and disease","volume":"20","author":"Jenkins","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.chom.2025.04.020_bib92","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189965","article-title":"Fatty acids in non-alcoholic steatohepatitis: Focus on pentadecanoic acid","volume":"12","author":"Yoo","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.chom.2025.04.020_bib93","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/s41564-023-01418-7","article-title":"Parabacteroides distasonis uses dietary inulin to suppress NASH via its metabolite pentadecanoic acid","volume":"8","author":"Wei","year":"2023","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.chom.2025.04.020_bib94","first-page":"1","article-title":"Indole-3-propionic acid inhibits gut dysbiosis and endotoxin leakage to attenuate steatohepatitis in rats","volume":"51","author":"Zhao","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.chom.2025.04.020_bib95","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.3390\/nu13103509","article-title":"Indole-3-Propionic Acid, a Gut-Derived Tryptophan Metabolite, Associates with Hepatic Fibrosis","volume":"13","author":"Sehgal","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.chom.2025.04.020_bib96","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.celrep.2018.03.109","article-title":"Gut Microbiota-Derived Tryptophan Metabolites Modulate Inflammatory Response in Hepatocytes and Macrophages","volume":"23","author":"Krishnan","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.chom.2025.04.020_bib97","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.3390\/nu11092062","article-title":"Indole-3-Acetic Acid Alleviates Nonalcoholic Fatty Liver Disease in Mice via Attenuation of Hepatic Lipogenesis, and Oxidative and Inflammatory Stress","volume":"11","author":"Ji","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.chom.2025.04.020_bib98","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.87458","article-title":"Oral supplementation of gut microbial metabolite indole-3-acetate alleviates diet-induced steatosis and inflammation in mice","volume":"12","author":"Ding","year":"2024","journal-title":"eLife"},{"key":"10.1016\/j.chom.2025.04.020_bib99","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/s42255-024-01041-8","article-title":"The microbial metabolite agmatine acts as an FXR agonist to promote polycystic ovary syndrome in female mice","volume":"6","author":"Yun","year":"2024","journal-title":"Nat. Metab."},{"key":"10.1016\/j.chom.2025.04.020_bib100","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910688","article-title":"Inhibition of Atherosclerosis and Liver Steatosis by Agmatine in Western Diet-Fed apoE-Knockout Mice Is Associated with Decrease in Hepatic De Novo Lipogenesis and Reduction in Plasma Triglyceride\/High-Density Lipoprotein Cholesterol Ratio","volume":"22","author":"Wi\u015bniewska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.chom.2025.04.020_bib101","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.14309\/ajg.0000000000001375","article-title":"Safety, Tolerability, and Biologic Activity of AXA1125 and AXA1957 in Subjects With Nonalcoholic Fatty Liver Disease","volume":"116","author":"Harrison","year":"2021","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.chom.2025.04.020_bib102","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3390\/nu11030705","article-title":"Non-Alcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: Role of Circulating Branched-Chain Amino Acids","volume":"11","author":"van den Berg","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.chom.2025.04.020_bib103","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.92244","article-title":"Metabolomic Biomarkers in the Diagnosis of Non-Alcoholic Fatty Liver Disease","volume":"19","author":"Chashmniam","year":"2019","journal-title":"Hepat. Mon."},{"key":"10.1016\/j.chom.2025.04.020_bib104","doi-asserted-by":"crossref","DOI":"10.1111\/ijpo.12739","article-title":"A branched-chain amino acid-based metabolic score can predict liver fat in children and adolescents with severe obesity","volume":"16","author":"Lischka","year":"2021","journal-title":"Pediatr. Obes."},{"key":"10.1016\/j.chom.2025.04.020_bib105","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/s41591-018-0061-3","article-title":"Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women","volume":"24","author":"Hoyles","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.chom.2025.04.020_bib106","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.chom.2024.04.004","article-title":"Microbiota metabolism of intestinal amino acids impacts host nutrient homeostasis and physiology","volume":"32","author":"Li","year":"2024","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.chom.2025.04.020_bib107","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/hep.29892","article-title":"Link between gut-microbiome derived metabolite and shared gene-effects with hepatic steatosis and fibrosis in NAFLD","volume":"68","author":"Caussy","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.chom.2025.04.020_bib108","doi-asserted-by":"crossref","first-page":"101341","DOI":"10.1016\/j.xcrm.2023.101341","article-title":"Potential therapeutic implications of histidine catabolism by the gut microbiota in NAFLD patients with morbid obesity","volume":"4","author":"Quesada-V\u00e1zquez","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.chom.2025.04.020_bib109","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s12866-022-02704-w","article-title":"Marked gut microbiota dysbiosis and increased imidazole propionate are associated with a NASH G\u00f6ttingen Minipig model","volume":"22","author":"L\u00fctzh\u00f8ft","year":"2022","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.chom.2025.04.020_bib110","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02663-22","article-title":"Identification of Gut Microbial Lysine and Histidine Degradation and CYP-Dependent Metabolites as Biomarkers of Fatty Liver Disease","volume":"14","author":"Driuchina","year":"2023","journal-title":"mBio"},{"key":"10.1016\/j.chom.2025.04.020_bib111","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.chom.2024.04.017","article-title":"Candida albicans accelerates atherosclerosis by activating intestinal hypoxia-inducible factor2\u03b1 signaling","volume":"32","author":"Wang","year":"2024","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.chom.2025.04.020_bib112","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41586-022-05299-4","article-title":"Gut bacteria alleviate smoking-related NASH by degrading gut nicotine","volume":"610","author":"Chen","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.chom.2025.04.020_bib113","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.2337\/dc17-1318","article-title":"Specific Hepatic Sphingolipids Relate to Insulin Resistance, Oxidative Stress, and Inflammation in Nonalcoholic Steatohepatitis","volume":"41","author":"Apostolopoulou","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.chom.2025.04.020_bib114","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.cmet.2015.06.007","article-title":"Targeted Induction of Ceramide Degradation Leads to Improved Systemic Metabolism and Reduced Hepatic Steatosis","volume":"22","author":"Xia","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.chom.2025.04.020_bib115","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/s42255-019-0134-8","article-title":"Metabolic Messengers: ceramides","volume":"1","author":"Summers","year":"2019","journal-title":"Nat. Metab."},{"key":"10.1016\/j.chom.2025.04.020_bib116","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41575-021-00472-y","article-title":"Dietary carbohydrates and fats in nonalcoholic fatty liver disease","volume":"18","author":"Yki-J\u00e4rvinen","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.chom.2025.04.020_bib117","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1038\/s42255-022-00700-y","article-title":"A researcher\u2019s guide to preclinical mouse NASH models","volume":"4","author":"Gallage","year":"2022","journal-title":"Nat. Metab."},{"key":"10.1016\/j.chom.2025.04.020_bib118","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41564-018-0294-4","article-title":"Gut bacterial phospholipase Ds support disease-associated metabolism by generating choline","volume":"4","author":"Chittim","year":"2019","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.chom.2025.04.020_bib119","article-title":"Trimethylamine-N-oxide (TMAO) mediates the crosstalk between the gut microbiota and hepatic vascular niche to alleviate liver fibrosis in nonalcoholic steatohepatitis","volume":"13","author":"Zhou","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.chom.2025.04.020_bib120","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3390\/metabo12121243","article-title":"Trimethylamine N-Oxide Levels in Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis","volume":"12","author":"Theofilis","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.chom.2025.04.020_bib121","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41522-022-00273-4","article-title":"Integrated metagenomics identifies a crucial role for trimethylamine-producing Lachnoclostridium in promoting atherosclerosis","volume":"8","author":"Cai","year":"2022","journal-title":"NPJ Biofilms Microbiomes"},{"key":"10.1016\/j.chom.2025.04.020_bib122","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1111\/apt.18331","article-title":"Semaglutide 2.4 mg in Participants With Metabolic Dysfunction-Associated Steatohepatitis: Baseline Characteristics and Design of the Phase 3 ESSENCE Trial","volume":"60","author":"Newsome","year":"2024","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.chom.2025.04.020_bib123","doi-asserted-by":"crossref","DOI":"10.1126\/science.add5787","article-title":"Microbial-host-isozyme analyses reveal microbial DPP4 as a potential antidiabetic target","volume":"381","author":"Wang","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.chom.2025.04.020_bib124","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s40618-020-01392-5","article-title":"Circulating dipeptidyl peptidase-4 is independently associated with the presence and severity of NAFLD\/NASH in individuals with and without obesity and metabolic disease","volume":"44","author":"Barchetta","year":"2021","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.chom.2025.04.020_bib125","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.molmet.2017.07.016","article-title":"Elevated hepatic DPP4 activity promotes insulin resistance and non-alcoholic fatty liver disease","volume":"6","author":"Baumeier","year":"2017","journal-title":"Mol. Metab."},{"key":"10.1016\/j.chom.2025.04.020_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2023.101806","article-title":"Gemigliptin, a DPP4 inhibitor, ameliorates nonalcoholic steatohepatitis through AMP-activated protein kinase-independent and ULK1-mediated autophagy","volume":"78","author":"Song","year":"2023","journal-title":"Mol. Metab."},{"key":"10.1016\/j.chom.2025.04.020_bib127","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1136\/gutjnl-2021-326874","article-title":"Current therapies and new developments in NASH","volume":"71","author":"Dufour","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.chom.2025.04.020_bib128","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41591-023-02242-6","article-title":"Challenges and opportunities in NASH drug development","volume":"29","author":"Harrison","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.chom.2025.04.020_bib129","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914918","article-title":"Prebiotics and Probiotics: Therapeutic Tools for Nonalcoholic Fatty Liver Disease","volume":"24","author":"Mijangos-Trejo","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.chom.2025.04.020_bib130","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2221485","article-title":"Akkermansia muciniphila inhibits nonalcoholic steatohepatitis by orchestrating TLR2-activated \u03b3\u03b4T17 cell and macrophage polarization","volume":"15","author":"Han","year":"2023","journal-title":"Gut Microbes"},{"key":"10.1016\/j.chom.2025.04.020_bib131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2021.1927633","article-title":"Gut Akkermansia muciniphila ameliorates metabolic dysfunction-associated fatty liver disease by regulating the metabolism of L-aspartate via gut-liver axis","volume":"13","author":"Rao","year":"2021","journal-title":"Gut Microbes"},{"key":"10.1016\/j.chom.2025.04.020_bib132","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s11684-022-0960-z","article-title":"Role of Akkermansia muciniphila in the development of nonalcoholic fatty liver disease: current knowledge and perspectives","volume":"16","author":"Han","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.chom.2025.04.020_bib133","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nm.4236","article-title":"A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice","volume":"23","author":"Plovier","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.chom.2025.04.020_bib134","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jhepr.2019.04.004","article-title":"The role of the gut microbiome in chronic liver disease: the clinical evidence revised","volume":"1","author":"Schwenger","year":"2019","journal-title":"JHEP Rep."},{"key":"10.1016\/j.chom.2025.04.020_bib135","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.759306","article-title":"Effect of Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial","volume":"12","author":"Xue","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.chom.2025.04.020_bib136","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/hep4.1601","article-title":"Donor Fecal Microbiota Transplantation Alters Gut Microbiota and Metabolites in Obese Individuals With Steatohepatitis","volume":"4","author":"Witjes","year":"2020","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.chom.2025.04.020_bib137","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.14309\/ajg.0000000000000661","article-title":"Allogenic Fecal Microbiota Transplantation in Patients With Nonalcoholic Fatty Liver Disease Improves Abnormal Small Intestinal Permeability: A Randomized Control Trial","volume":"115","author":"Craven","year":"2020","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.chom.2025.04.020_bib138","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003051","article-title":"Fecal microbiota transplantation for the improvement of metabolism in obesity: The FMT-TRIM double-blind placebo-controlled pilot trial","volume":"17","author":"Yu","year":"2020","journal-title":"PLoS Med."},{"key":"10.1016\/j.chom.2025.04.020_bib139","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/hep.30037","article-title":"Antibiotic-Associated Disruption of Microbiota Composition and Function in Cirrhosis Is Restored by Fecal Transplant","volume":"68","author":"Bajaj","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.chom.2025.04.020_bib140","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.jhep.2021.08.003","article-title":"Intestinal virome and therapeutic potential of bacteriophages in liver disease","volume":"75","author":"Hsu","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.chom.2025.04.020_bib141","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-39028-w","article-title":"Bacteriophage targeting microbiota alleviates non-alcoholic fatty liver disease induced by high alcohol-producing Klebsiella pneumoniae","volume":"14","author":"Gan","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chom.2025.04.020_bib142","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jhep.2024.08.008","article-title":"Thyroid hormone receptor-beta agonist HSK31679 alleviates MASLD by modulating gut microbial sphingolipids","volume":"82","author":"Zhang","year":"2025","journal-title":"J. Hepatol."},{"key":"10.1016\/j.chom.2025.04.020_bib143","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1021\/jacs.8b04883","article-title":"Structure-Guided Identification of a Small Molecule That Inhibits Anaerobic Choline Metabolism by Human Gut Bacteria","volume":"141","author":"Orman","year":"2019","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.chom.2025.04.020_bib144","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41392-022-01027-6","article-title":"Berberine treats atherosclerosis via a vitamine-like effect down-regulating Choline-TMA-TMAO production pathway in gut microbiota","volume":"7","author":"Ma","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.chom.2025.04.020_bib145","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s41589-020-0467-3","article-title":"Development of a covalent inhibitor of gut bacterial bile salt hydrolases","volume":"16","author":"Adhikari","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.chom.2025.04.020_bib146","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1021\/acschembio.1c00192","article-title":"A Gut-Restricted Lithocholic Acid Analog as an Inhibitor of Gut Bacterial Bile Salt Hydrolases","volume":"16","author":"Adhikari","year":"2021","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.chom.2025.04.020_bib147","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cmet.2020.11.010","article-title":"Current Concepts, Opportunities, and Challenges of Gut Microbiome-Based Personalized Medicine in Nonalcoholic Fatty Liver Disease","volume":"33","author":"Sharpton","year":"2021","journal-title":"Cell Metab."}],"container-title":["Cell Host & Microbe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931312825001532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931312825001532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T08:12:38Z","timestamp":1778832758000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931312825001532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":147,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1931312825001532"],"URL":"https:\/\/doi.org\/10.1016\/j.chom.2025.04.020","relation":{},"ISSN":["1931-3128"],"issn-type":[{"value":"1931-3128","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gut microbial enzymes and metabolic dysfunction-associated steatohepatitis: Function, mechanism, and therapeutic prospects","name":"articletitle","label":"Article Title"},{"value":"Cell Host & Microbe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chom.2025.04.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}